[144] ABEONA THERAPEUTICS INC. SEC Filing

Rhea-AI Filing Summary

Abeona Therapeutics (ABEO) Form 144 shows a proposed sale of 17,376 shares of common stock through Stifel Nicolaus & Company on 09/22/2025 with an aggregate market value of $101,749. The filing lists total shares outstanding of 51,156,736, so the proposed sale equals a small fraction of the outstanding float. The notice records an acquisition of 1,360 shares as Restricted Stock Units on 09/21/2025 with cash payment on 09/22/2025. It also discloses a sale by Brendan O'Malley of 17,428 shares on 07/09/2025 for gross proceeds of $102,053. The filer attests there is no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider sale disclosed; transaction size is immaterial relative to outstanding shares, so market impact is likely limited.

The Form 144 reports a proposed sale of 17,376 shares valued at $101,749 against 51,156,736 shares outstanding, representing roughly 0.034% of outstanding shares. That scale suggests limited market impact from this single proposed transaction. The filing also documents a recent restricted stock unit vesting (1,360 shares) and a prior sale by Brendan O'Malley (17,428 shares) in July generating $102,053. From a trading-volume and dilution perspective, these amounts are small. The filing fulfills Rule 144 notice requirements and provides transparent disclosure of the insider activity.

Corporate Governance Expert

TL;DR: Form 144 indicates insider compliance with disclosure rules; recurring insider sales warrant monitoring but are not materially large here.

The document is a routine Rule 144 notice showing proposed and recent insider sales and an RSU acquisition. The signer’s representation that no material nonpublic information is known is standard language on this form. While insider sales can inform governance and confidence discussions, the magnitude reported—both the planned 17,376-share sale and the July 9 sale of 17,428 shares—are small relative to total shares outstanding, reducing immediate governance concern. Continued patterns of sales or larger dispositions would be more material.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	17376	101749.00	51156736	09/22/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/21/2025	Restricted Stock Units	Issuer			1360	09/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brendan O'Malley 6555 Carnegie Ave Fl 4 Cleveland OH 44103	Common Stock	07/09/2025	17428	102053.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ABEO Form 144 disclose about proposed insider sales?

The filing reports a proposed sale of 17,376 common shares through Stifel Nicolaus on 09/22/2025 with an aggregate market value of $101,749.

How large is the proposed sale relative to Abeona's outstanding shares (ABEO)?

The filing lists 51,156,736 shares outstanding, so the proposed sale (~17,376 shares) represents roughly 0.034% of outstanding shares.

Did the filer recently acquire any shares before this proposed sale?

Yes. The filer acquired 1,360 shares as Restricted Stock Units on 09/21/2025, with payment recorded on 09/22/2025.

Were there other recent sales by related persons disclosed?

The filing shows Brendan O'Malley sold 17,428 shares on 07/09/2025 for gross proceeds of $102,053.

Does the Form 144 include any statement about undisclosed material information?

Yes. The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed.